Variant report
Variant | nsv961639 |
---|---|
Chromosome Location | chr2:114333474-114336681 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:140)
- CpG islands (count:122)
- Chromatin interactive region (count:0)
- LncRNA region (count:15)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr2:114331512-114333637 | K562 | blood: | n/a | n/a |
2 | CBX3 | chr2:114335770-114336797 | K562 | blood: | n/a | n/a |
3 | CBX3 | chr2:114334040-114334625 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr2:114334095-114334557 | K562 | blood: | n/a | n/a |
5 | CEBPD | chr2:114333969-114334623 | K562 | blood: | n/a | n/a |
6 | CEBPD | chr2:114336333-114336751 | K562 | blood: | n/a | n/a |
7 | EBF1 | chr2:114336454-114336671 | GM12878 | blood: | n/a | n/a |
8 | EP300 | chr2:114335819-114336062 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr2:114335752-114336042 | GM12878 | blood: | n/a | n/a |
10 | EP300 | chr2:114336425-114336759 | GM12878 | blood: | n/a | chr2:114336735-114336749 |
11 | FOSL2 | chr2:114334040-114334650 | HepG2 | liver: | n/a | chr2:114334231-114334240 chr2:114334230-114334241 chr2:114334231-114334238 |
12 | FOSL2 | chr2:114334217-114334636 | HepG2 | liver: | n/a | chr2:114334231-114334240 chr2:114334230-114334241 chr2:114334231-114334238 |
13 | FOSL2 | chr2:114335695-114336861 | HepG2 | liver: | n/a | n/a |
14 | FOSL2 | chr2:114335663-114337061 | HepG2 | liver: | n/a | n/a |
15 | FOSL2 | chr2:114334881-114335561 | HepG2 | liver: | n/a | n/a |
16 | FOXA1 | chr2:114335759-114336496 | HepG2 | liver: | n/a | n/a |
17 | GABPA | chr2:114334219-114334595 | Hela-S3 | cervix: | n/a | n/a |
18 | GABPA | chr2:114336448-114336692 | Hela-S3 | cervix: | n/a | n/a |
19 | GABPA | chr2:114334391-114334518 | Hela-S3 | cervix: | n/a | n/a |
20 | GABPA | chr2:114333012-114333586 | Hela-S3 | cervix: | n/a | n/a |
21 | GABPA | chr2:114335694-114336368 | Hela-S3 | cervix: | n/a | n/a |
22 | GABPA | chr2:114336406-114336684 | Hela-S3 | cervix: | n/a | n/a |
23 | GABPA | chr2:114335217-114335554 | Hela-S3 | cervix: | n/a | n/a |
24 | GABPA | chr2:114334779-114335207 | Hela-S3 | cervix: | n/a | n/a |
25 | GABPA | chr2:114335890-114336307 | Hela-S3 | cervix: | n/a | n/a |
26 | GABPA | chr2:114334995-114335202 | Hela-S3 | cervix: | n/a | n/a |
27 | GATA2 | chr2:114333968-114335549 | K562 | blood: | n/a | chr2:114334232-114334241 |
28 | GATA2 | chr2:114335788-114337170 | K562 | blood: | n/a | n/a |
29 | GATA2 | chr2:114331322-114333699 | K562 | blood: | n/a | n/a |
30 | HEY1 | chr2:114335963-114336178 | HepG2 | liver: | n/a | n/a |
31 | HEY1 | chr2:114331431-114333666 | K562 | blood: | n/a | n/a |
32 | HEY1 | chr2:114334259-114334524 | HepG2 | liver: | n/a | n/a |
33 | HEY1 | chr2:114335699-114336544 | HepG2 | liver: | n/a | n/a |
34 | HEY1 | chr2:114331291-114335500 | K562 | blood: | n/a | n/a |
35 | HEY1 | chr2:114333928-114335338 | K562 | blood: | n/a | n/a |
36 | HEY1 | chr2:114335673-114336740 | K562 | blood: | n/a | n/a |
37 | HEY1 | chr2:114335663-114336784 | K562 | blood: | n/a | n/a |
38 | JUND | chr2:114334193-114334605 | HepG2 | liver: | n/a | chr2:114334231-114334240 chr2:114334230-114334241 chr2:114334231-114334238 |
39 | JUND | chr2:114335877-114336353 | HepG2 | liver: | n/a | n/a |
40 | JUND | chr2:114334690-114335116 | HepG2 | liver: | n/a | n/a |
41 | JUND | chr2:114335762-114336722 | HepG2 | liver: | n/a | n/a |
42 | JUND | chr2:114335551-114335713 | HepG2 | liver: | n/a | n/a |
43 | JUND | chr2:114334993-114335113 | HepG2 | liver: | n/a | n/a |
44 | JUND | chr2:114335243-114335448 | HepG2 | liver: | n/a | n/a |
45 | NR2F2 | chr2:114331376-114333702 | K562 | blood: | n/a | n/a |
46 | NR2F2 | chr2:114333996-114334665 | K562 | blood: | n/a | n/a |
47 | NR2F2 | chr2:114336072-114336800 | K562 | blood: | n/a | n/a |
48 | NR2F2 | chr2:114334103-114334559 | K562 | blood: | n/a | n/a |
49 | NR2F2 | chr2:114335265-114336969 | K562 | blood: | n/a | n/a |
50 | PAX5 | chr2:114335835-114336755 | GM12878 | blood: | n/a | chr2:114336638-114336656 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:114333496-114333546 | HEEpiC | esophagus: | n/a |
2 | chr2:114333496-114333546 | MCF-7 | breast: | n/a |
3 | chr2:114334065-114334115 | SKMC | muscle: | n/a |
4 | chr2:114334065-114334115 | PANC-1 | pancreas: | n/a |
5 | chr2:114333496-114333546 | H1-hESC | embryonic stem cell: | embryo |
6 | chr2:114333496-114333546 | HUVEC | blood vessel: | n/a |
7 | chr2:114333496-114333546 | HCPEpiC | choroid plexus: | n/a |
8 | chr2:114334065-114334115 | HRCEpiC | kidney: | n/a |
9 | chr2:114333496-114333546 | A549 | lung: | n/a |
10 | chr2:114334065-114334115 | HRPEpiC | eye: | n/a |
11 | chr2:114333496-114333546 | Caco-2 | colon: | n/a |
12 | chr2:114334065-114334115 | NHDF-neo | bronchial: | n/a |
13 | chr2:114333496-114333546 | HPAEpiC | pulmonary alveolar: | n/a |
14 | chr2:114334065-114334115 | SK-N-SH_RA | brain: | n/a |
15 | chr2:114334065-114334115 | Caco-2 | colon: | n/a |
16 | chr2:114334065-114334115 | BE2_C | brain: | n/a |
17 | chr2:114334065-114334115 | HRE | kidney: | n/a |
18 | chr2:114333496-114333546 | GM12892 | blood: | n/a |
19 | chr2:114334065-114334115 | AG09319 | gingival: | n/a |
20 | chr2:114334065-114334115 | GM12878 | blood: | n/a |
21 | chr2:114333496-114333546 | SK-N-SH_RA | brain: | n/a |
22 | chr2:114334065-114334115 | NB4 | blood: | n/a |
23 | chr2:114334065-114334115 | GM12891 | blood: | n/a |
24 | chr2:114333496-114333546 | Hepatocyte | liver: | n/a |
25 | chr2:114334065-114334115 | HUVEC | blood vessel: | n/a |
26 | chr2:114333496-114333546 | IMR90 | lung: | fetal |
27 | chr2:114333496-114333546 | SAEC | small airway: | n/a |
28 | chr2:114333496-114333546 | GM19239 | blood: | n/a |
29 | chr2:114334065-114334115 | HCM | heart: | n/a |
30 | chr2:114334065-114334115 | ovcar-3 | ovarian: | n/a |
31 | chr2:114334065-114334115 | PFSK-1 | brain: | n/a |
32 | chr2:114333496-114333546 | PFSK-1 | brain: | n/a |
33 | chr2:114333496-114333546 | GM12891 | blood: | n/a |
34 | chr2:114334065-114334115 | HCF | heart: | n/a |
35 | chr2:114334065-114334115 | HPAEpiC | pulmonary alveolar: | n/a |
36 | chr2:114333496-114333546 | U87 | brain: | n/a |
37 | chr2:114334065-114334115 | K562 | blood: | n/a |
38 | chr2:114333496-114333546 | HL-60 | blood: | n/a |
39 | chr2:114334065-114334115 | HMEC | breast: | n/a |
40 | chr2:114334065-114334115 | AG04450 | lung: | fetal |
41 | chr2:114333496-114333546 | AG04449 | skin: | fetal |
42 | chr2:114334065-114334115 | AG09309 | skin: | n/a |
43 | chr2:114334065-114334115 | Jurkat | blood: | n/a |
44 | chr2:114334065-114334115 | MCF-7 | breast: | n/a |
45 | chr2:114333496-114333546 | Jurkat | blood: | n/a |
46 | chr2:114334065-114334115 | HCT-116 | colon: | n/a |
47 | chr2:114333496-114333546 | HRPEpiC | eye: | n/a |
48 | chr2:114333496-114333546 | NHBE | bronchial: | n/a |
49 | chr2:114333496-114333546 | HMEC | breast: | n/a |
50 | chr2:114334065-114334115 | ECC-1 | luminal epithelium: | n/a |
No data |
(count:15 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RABL2A-2 | chr2:114335559-114335763 | ENSG00000226516.3 |
2 | lnc-RABL2A-2 | chr2:114335559-114335763 | ENSG00000226516 |
3 | lnc-RABL2A-2 | chr2:114334959-114335319 | XLOC_001632 |
4 | lnc-RABL2A-2 | chr2:114335866-114336428 | XLOC_001632 |
5 | lnc-RABL2A-2 | chr2:114335192-114335319 | ENSG00000226516 |
6 | lnc-RABL2A-2 | chr2:114336158-114336486 | XLOC_001632 |
7 | lnc-RABL2A-2 | chr2:114335559-114335961 | XLOC_001632 |
8 | lnc-RABL2A-2 | chr2:114335866-114336429 | ENSG00000226516.3 |
9 | lnc-RABL2A-2 | chr2:114334959-114335319 | ENSG00000226516.3 |
10 | lnc-RABL2A-2 | chr2:114334959-114335319 | ENSG00000226516.3 |
11 | lnc-AC016745.1-6 | chr2:114335509-114335609 | l_1930_chr2:114303057-114317403_testes |
12 | lnc-RABL2A-2 | chr2:114335559-114336429 | ENSG00000226516.3 |
13 | lnc-RABL2A-2 | chr2:114335559-114335763 | XLOC_001632 |
14 | lnc-RABL2A-2 | chr2:114334959-114335319 | XLOC_001632 |
15 | lnc-RABL2A-2 | chr2:114335866-114336353 | ENSG00000226516 |
No data |
No data |
Variant related genes | Relation type |
---|---|
FAM138B | TF binding region |
WASH2P | TF binding region |
FAM138B | CpG island |
WASH2P | CpG island |
C11orf54 | miRNA target sites |
C10orf88 | miRNA target sites |
C11orf41 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564208816 | chr2:114333474-114333475 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs533071104 | chr2:114333496-114333497 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs7588688 | chr2:114333535-114333536 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs56272028 | chr2:114333572-114333573 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs546772585 | chr2:114333584-114333585 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs566684004 | chr2:114333609-114333610 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs529144924 | chr2:114333619-114333620 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs549294588 | chr2:114333628-114333629 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs3877493 | chr2:114333646-114333647 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs568342265 | chr2:114333710-114333711 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs566798045 | chr2:114333751-114333752 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs537500550 | chr2:114333763-114333764 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs60693740 | chr2:114333780-114333781 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs557027697 | chr2:114333829-114333830 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs570563620 | chr2:114333893-114333894 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs539565596 | chr2:114333935-114333936 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs2758047 | chr2:114333948-114333949 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs141686911 | chr2:114333950-114333951 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs10864917 | chr2:114333971-114333972 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs573418239 | chr2:114334044-114334045 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs6727150 | chr2:114334048-114334049 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs542132748 | chr2:114334060-114334061 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs6740116 | chr2:114334066-114334067 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs2441627 | chr2:114334075-114334076 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs556069165 | chr2:114334080-114334081 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs149457858 | chr2:114334083-114334084 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs6730337 | chr2:114334102-114334103 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs2441626 | chr2:114334106-114334107 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs185880806 | chr2:114334108-114334109 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs6712386 | chr2:114334109-114334110 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs564076404 | chr2:114334110-114334111 | Enhancers Weak transcription | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs533033721 | chr2:114334126-114334127 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs148417821 | chr2:114334147-114334148 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs56326313 | chr2:114334161-114334162 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs415337 | chr2:114334175-114334176 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs455157 | chr2:114334189-114334190 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs10864918 | chr2:114334190-114334191 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs2441625 | chr2:114334195-114334196 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs141145756 | chr2:114334207-114334208 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs10864919 | chr2:114334215-114334216 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs6730472 | chr2:114334216-114334217 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs560077304 | chr2:114334225-114334226 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs191869042 | chr2:114334231-114334232 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs549004590 | chr2:114334264-114334265 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs6715502 | chr2:114334272-114334273 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs6743126 | chr2:114334275-114334276 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs2418670 | chr2:114334305-114334306 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs147518320 | chr2:114334361-114334362 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs113533434 | chr2:114334416-114334417 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs531511745 | chr2:114334430-114334431 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:114311400-114340400 | Weak transcription | Fetal Stomach | stomach |
2 | chr2:114314600-114339000 | Weak transcription | NHLF | lung |
3 | chr2:114329600-114341000 | Weak transcription | NHDF-Ad | bronchial |
4 | chr2:114330600-114334400 | Enhancers | K562 | blood |
5 | chr2:114333200-114334000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr2:114333200-114340000 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
7 | chr2:114333200-114340200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
8 | chr2:114334000-114335000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr2:114334200-114334800 | Enhancers | Fetal Muscle Leg | muscle |
10 | chr2:114334400-114336600 | Weak transcription | K562 | blood |
11 | chr2:114334800-114340200 | Weak transcription | Fetal Muscle Leg | muscle |
12 | chr2:114335000-114336600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr2:114336600-114336800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
14 | chr2:114336600-114337000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr2:114336600-114337000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr2:114336600-114340200 | Enhancers | K562 | blood |